Rhythm's $25M Series B to Satisfy Clinical Data Appetite
A $25 million Series B financing disclosed Wednesday morning will bring the total amount invested in Rhythm Pharmaceuticals Inc. to $65 million, according to Bart Henderson, founder and president of the Boston-based company.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter